Articles dans des revues avec comité de lecture (7)
  1. 1. Rossi, M., Korpak, K., Doerfler, A., & Zouaoui Boudjeltia, K. (2021). Deciphering the Role of Heme Oxygenase-1 (HO-1) Expressing Macrophages in Renal Ischemia-Reperfusion Injury. Biomedicines, 9(3). doi:10.3390/biomedicines9030306
  2. 2. Rossi, M., Piagnerelli, M., Van Meerhaeghe, A., & Zouaoui Boudjeltia, K. (2020). Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome. Medical hypotheses, 144, 110242. doi:10.1016/j.mehy.2020.110242
  3. 3. Rossi, M., Piagnerelli, M., Van Meerhaeghe, A., & Zouaoui Boudjeltia, K. (2020). Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome. Medical hypotheses, 144, 110242. doi:10.1016/j.mehy.2020.110242
  4. 4. Rossi, M., Delbauve, S., Roumeguere, T., Wespes, E., Leo, O., Flamand, V., Le Moine, A., & Hougardy, J.-M. (2019). HO-1 mitigates acute kidney injury and subsequent kidney-lung cross-talk. Free radical research, 53(9-10), 1035-1043. doi:10.1080/10715762.2019.1668936
  5. 5. Rossi, M., Delbauve, S., Wespes, E., Roumeguere, T., Leo, O., Flamand, V., Le Moine, A., & Hougardy, J.-M. (2018). Dual effect of hemin on renal ischemia-reperfusion injury. Biochemical and biophysical research communications, 503(4), 2820-2825. doi:10.1016/j.bbrc.2018.08.046
  6. 6. Rossi, M., Antoine, T., Delbauve, S., Preyat, N., Soares, M. P., Roumeguere, T., Leo, O., Flamand, V., Le Moine, A., & Hougardy, J.-M. (2017). Specific expression of heme oxygenase-1 by myeloid cells modulates renal ischemia-reperfusion injury. Scientific reports, 7(1), 197. doi:10.1038/s41598-017-00220-w
  7. 7. Rossi, M., & Roumeguere, T. (2010). Silodosin in the treatment of benign prostatic hyperplasia. Drug Design, Development and Therapy, 4, 291-297. doi:10.2147/DDDT.S10428
    8.   Articles dans des revues sans comité de lecture (2)
  8. 1. Rossi, M., Wespes, E., & Roumeguere, T. (2011). Silodosine: un nouvel alpha-bloquant pour le traitement de l’hyperplasie bénigne de la prostate. Andro-logic, 7(6), 1-6.
  9. 2. Rossi, M., & Roumeguere, T. (2011). Silodosin: a new ultra selective alpha blocker for benign prostate hypertrophy. Urobel magazine, 21, 16-18.
    10.   Thèses et mémoires (1)
  10. 1. Rossi, M. (2020). Contribution of myeloid HO-1 to the modulation of renal ischemia-reperfusion injury: Effect of myeloid HO-1 induction with hemin as a preemptive treatment strategy against renal ischemia-reperfusion injury (Thèse doctorale non-publiée). Université libre de Bruxelles, Faculté de Médecine – Sciences médicales, Bruxelles.